top of page

Nasal Research Compounds: NAD+, Selank, Semax and DSIP

Writer: Colt Clemons
Colt Clemons
Feb 12
2 min read

Updated: Oct 10

Nasal delivery is a research topic, not evidence that a particular product is effective or suitable for human use. NAD+, Selank, Semax and delta sleep-inducing peptide (DSIP) are different compounds with different evidence bases. This guide separates their identities, study models and limits.


Premier Aminos DSIP research nasal spray
Premier Aminos DSIP research nasal spray

Is NAD+ a peptide?


No. Nicotinamide adenine dinucleotide (NAD+) is a dinucleotide coenzyme, not a peptide. It should not be grouped chemically with Selank, Semax or DSIP. A compound’s biological role does not establish the performance of a nasal formulation.



What do Semax and Selank studies show?


A 2006 Semax study examined BDNF and trkB expression in rat hippocampus and reported changes in those measures. A separate 2008 Selank paper examined BDNF expression in rat hippocampus. These are animal research findings; they do not establish improvements in human focus, mood or anxiety from a retail nasal product.




Does the cited DSIP research validate nasal sleep claims?


No. A small double-blind study in 16 people with chronic insomnia evaluated intravenous DSIP, not a nasal spray. The authors described weak changes in some objective sleep measures and no improvement in subjective sleep quality, concluding that therapeutic benefit was limited. That study cannot substantiate claims that DSIP nasal sprays improve insomnia or avoid sedative side effects.



An earlier small trial reported different findings. Together, these papers show why study size, route and outcomes must be considered rather than treating a compound name as proof of a product benefit.



Does nasal delivery guarantee brain uptake?


No. Findings about a particular compound and experimental formulation do not validate all nasal products. A spray bottle alone does not establish delivered volume, absorption, stability, sterility or clinical benefit. Evidence for a single ingredient also does not establish the effect of a blend.



How should researchers evaluate a paper?


Identify the exact compound, study model, route, formulation, comparison group and measured endpoint. Distinguish a change in a laboratory marker from a demonstrated clinical outcome. Check whether the tested preparation matches the material being evaluated, and state clearly when that comparison has not been established.


Research scope and product information


This article summarizes research and does not provide administration, dosing or treatment instructions. Premier Aminos research compounds are offered for laboratory research, not human or animal consumption. Current listing details and site policies govern product information.



 
 
 

Comments


bottom of page